By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
MedsparkMedsparkMedspark
  • Home
  • News & Alerts
    News & AlertsShow More
    Ohio State and Microsoft build a hospital that senses itself
    By
    msadmin
    November 11, 2026
    Charta raises $55M to settle claims before doctors bill
    By
    msadmin
    November 11, 2026
    Oura spends $625M to put doctors behind its ring
    By
    msadmin
    November 11, 2026
    Google puts an agent layer under every hospital workflow
    By
    msadmin
    November 11, 2026
    XtalPi hands Pierre Fabre a molecule factory for stubborn cancer targets
    By
    msadmin
    November 10, 2026
  • Spotlight
    SpotlightShow More
    Robinhood Ventures Fund II brings retail capital to healthcare AI
    By
    msadmin
    August 13, 2026
    Adialante brings accessible MRI-based cancer screening
    By
    msadmin
    August 11, 2026
    CellType models biology so AI can discover drugs
    By
    msadmin
    August 11, 2026
    Healthcare AI startups in Robinhood Ventures Fund II
    By
    msadmin
    August 11, 2026
    OpenAI launches GPT-Rosalind for life sciences research
    By
    msadmin
    July 17, 2026
  • Articles
    ArticlesShow More
    Singapore clinics let an AI watch for referrals nobody ever sent
    By
    msadmin
    November 1, 2026
    An AI team of agents grades immunotherapy side effects
    By
    msadmin
    October 30, 2026
    Brain implant decoders fail when patients or hardware change, review warns
    By
    msadmin
    October 25, 2026
    Proteomics model picks breast cancer drugs from biopsies
    By
    msadmin
    September 10, 2026
    CRISP model reads frozen sections to steer cancer surgery
    By
    msadmin
    September 10, 2026
  • About
    • Mission
    • Services
    • Contact
  • Shop
    • All Items
    • By Category
    • Cart
  • Newsletter
Font ResizerAa
MedsparkMedspark
Font ResizerAa
  • Home
  • News & Alerts
  • Spotlight
  • Articles
  • About
  • Shop
  • Newsletter
  • Home
  • News & Alerts
  • Spotlight
  • Articles
  • About
    • Mission
    • Services
    • Contact
  • Shop
    • All Items
    • By Category
    • Cart
  • Newsletter
Follow US
News & Alerts

Insilico collects a milestone payment ten months into its Servier cancer pact

Insilico Medicine has banked an undisclosed milestone from Servier after nominating oncology targets and starting two programs.

MedSpark Staff
By
msadmin
MedSpark Staff
Bymsadmin
Medical, Healthcare, & Biotech/Pharma AI News
Follow:
Published: October 21, 2026
Share
2 Min Read
SHARE

Insilico Medicine has triggered the first discovery milestone in its oncology collaboration with Servier, earning an undisclosed payment from the French drugmaker. The company reported the milestone on Monday.

The partnership was signed in early 2026 and pairs Insilico’s Pharma.AI discovery engine with Servier’s oncology development and commercial reach. Under the terms, Insilico runs AI-driven discovery and early work, while Servier funds a share of research and takes over later clinical development. The deal carries up to $888M in potential payments, including $32M in upfront and near-term research funding.

In roughly 10 months the two companies launched two programs against difficult cancer pathways and finished nominating targets for both. The milestone payment follows the first program’s early discovery results, though the amount stays private.

Founder and chief executive Alex Zhavoronkov said the pace of getting two programs started inside a year was the point of the arrangement.

The news lands alongside a strong financial run for the Hong Kong-listed company. Insilico booked about $106M in revenue in the first half of 2026, up 287% year over year, and an adjusted net profit above $51M, its first profitable half since listing. Out-licensing and co-development deals with partners including Eli Lilly, Takeda, SK Biopharmaceuticals and Qilu Pharmaceutical drove most of that.

Milestone structures remain the industry’s preferred way to buy AI drug discovery. They keep upfront cash small while tying the real payout to molecules that survive preclinical work, a filter that has cleared few programs so far.

TAGGED:AI Drug DiscoveryInsilico Medicinelicensing dealsoncologyPharma.AIServier
SOURCES:RTTNews
Share This Article
Facebook Copy Link Print
MedSpark Staff
Bymsadmin
Follow:
Medical, Healthcare, & Biotech/Pharma AI News

You Might Also Like

News & Alerts

Emanuel essay says pairing clinicians with strong AI can lower accuracy

By
msadmin
September 13, 2026
News & Alerts

Carotid plaque AI flags stroke risk in under a second

By
msadmin
October 10, 2026
News & Alerts

Nature review catalogs the attack surface of clinical LLMs

By
msadmin
August 20, 2026
News & Alerts

NVIDIA and Foxconn Deploy Specialized AI Agent Workforces Across Taiwan Medical Centers

By
msadmin
June 19, 2026

AI news, analysis, and insights for healthcare, biotech, and pharma.

Facebook Twitter Youtube Linkedin
Quick Links
  • News & Alerts
  • Articles
  • Spotlight
  • Events
About Medspark
  • Mission
  • Services
  • Contact

© Copyright 2026 MedSpark. All rights reserved.

Privacy Policy | Legal